{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:13:33Z","timestamp":1790907213265,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12032-012-0285-x","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T13:24:40Z","timestamp":1340889880000},"page":"3416-3420","source":"Crossref","is-referenced-by-count":13,"title":["Extraperitoneal response to intraperitoneal immunotherapy with catumaxomab in a patient with cutaneous lymphangiosis carcinomatosa from ovarian cancer: a case report and review of the literature"],"prefix":"10.1007","volume":"29","author":[{"given":"H.","family":"Woopen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Darb-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Oskay-Oezcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"issue":"7","key":"285_CR1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1097-0142(19891001)64:7<1508::AID-CNCR2820640725>3.0.CO;2-V","volume":"64","author":"PG Rose","year":"1989","unstructured":"Rose PG, Piver MS, Tsukada Y, Lau TS. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer. 1989;64(7):1508\u201313.","journal-title":"Cancer"},{"issue":"2","key":"285_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1525-1438.2003.13054.x","volume":"13","author":"G Cormio","year":"2003","unstructured":"Cormio G, Rossi C, Cazzolla A, et al. Distant metastases in ovarian carcinoma. Int J Gynecol Cancer. 2003;13(2):125\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"285_CR3","first-page":"119","volume":"39","author":"PS Spencer","year":"1987","unstructured":"Spencer PS, Helm TN. Skin metastases in cancer patients. Cutis. 1987;39(2):119\u201321.","journal-title":"Cutis"},{"issue":"7","key":"285_CR4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO;2-V","volume":"60","author":"J Dauplat","year":"1987","unstructured":"Dauplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer. 1987;60(7):1561\u20136.","journal-title":"Cancer"},{"issue":"2","key":"285_CR5","first-page":"102","volume":"22","author":"RV Haughney","year":"2001","unstructured":"Haughney RV, Slade RJ, Brain AN. An isolated abdominal wall metastasis of ovarian carcinoma ten years after primary surgery. Eur J Gynaecol Oncol. 2001;22(2):102\u20133.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"9","key":"285_CR6","first-page":"2485","volume":"5","author":"AK Sood","year":"1999","unstructured":"Sood AK, Sorosky JI, Dolan M, Anderson B, Buller RE. Distant metastases in ovarian cancer: association with p53 mutations. Clin Cancer Res. 1999;5(9):2485\u201390.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"285_CR7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.1972.01620090034008","volume":"105","author":"MH Brownstein","year":"1972","unstructured":"Brownstein MH, Helwig EB. Patterns of cutaneous metastasis. Arch Dermatol. 1972;105(6):862\u20138.","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"285_CR8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1525-1438.2006.00486.x","volume":"16","author":"Z Yilmaz","year":"2006","unstructured":"Yilmaz Z, Bese T, Demirkiran F, et al. Skin metastasis in ovarian carcinoma. Int J Gynecol Cancer. 2006;16(Suppl 1):414\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"285_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1034\/j.1600-0412.2002.810621.x","volume":"81","author":"H Matsui","year":"2002","unstructured":"Matsui H, Suzuka K, Yamazawa K, et al. Scalp metastasis of a serous ovarian cancer. Acta Obstet Gynecol Scand. 2002;81(6):577\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"285_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/gyno.1994.1122","volume":"53","author":"P Traiman","year":"1994","unstructured":"Traiman P, de Luca LA, Bacchi CE. An extremely large, cauliflower-type, cutaneous metastasis of ovarian cancer associated with good prognosis. Gynecol Oncol. 1994;53(2):239\u201341.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"285_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0090-8258(03)00366-4","volume":"90","author":"R Schonmann","year":"2003","unstructured":"Schonmann R, Altaras M, Biron T, Bernheim J, Fishman A. Inflammatory skin metastases from ovarian carcinoma\u2014a case report and review of the literature. Gynecol Oncol. 2003;90(3):670\u20132.","journal-title":"Gynecol Oncol"},{"key":"285_CR12","unstructured":"Sehouli Jalid. Symptomorientierte Therapien: Aszites. In: Multimodales Management des Ovarialkarzinoms. Bremen: UNI-MED; 2006."},{"issue":"3","key":"285_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjc.6603881","volume":"97","author":"P Ruf","year":"2007","unstructured":"Ruf P, Gires O, J\u00e4ger M, Fellinger K, Atz J, Lindhofer H. Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. Br J Cancer. 2007;97(3):315\u201321.","journal-title":"Br J Cancer"},{"issue":"10","key":"285_CR14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s001099900038","volume":"77","author":"M Balzar","year":"1999","unstructured":"Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17\u20131A antigen (Ep-CAM). J Mol Med. 1999;77(10):699\u2013712.","journal-title":"J Mol Med"},{"issue":"1","key":"285_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","volume":"35","author":"PT Went","year":"2004","unstructured":"Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol. 2004;35(1):122\u20138.","journal-title":"Hum Pathol"},{"issue":"5","key":"285_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","volume":"64","author":"G Spizzo","year":"2011","unstructured":"Spizzo G, Fong D, Wurm M, et al. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. J Clin Pathol. 2011;64(5):415\u201320.","journal-title":"J Clin Pathol"},{"issue":"1","key":"285_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-11-2235","volume":"72","author":"M J\u00e4ger","year":"2012","unstructured":"J\u00e4ger M, Schoberth A, Ruf P, et al. Immunomonitoring results of a phase II\/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3). Cancer Res. 2012;72(1):24\u201332.","journal-title":"Cancer Res"},{"issue":"13","key":"285_CR18","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1158\/1078-0432.CCR-06-2769","volume":"13","author":"A Burges","year":"2007","unstructured":"Burges A, Wimberger P, K\u00fcmper C, et al. Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I\/II study. Clin Cancer Res. 2007;13(13):3899\u2013905.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"285_CR19","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","volume":"127","author":"MM Heiss","year":"2010","unstructured":"Heiss MM, Murawa P, Koralewski P, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II\/III trial. Int J Cancer. 2010;127(9):2209\u201321.","journal-title":"Int J Cancer"},{"issue":"5","key":"285_CR20","first-page":"1787","volume":"29","author":"P Wimberger","year":"2009","unstructured":"Wimberger P, Heubner M, Lindhofer H, J\u00e4ger M, Kimmig R, Kasimir-Bauer S. Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer. Anticancer Res. 2009;29(5):1787\u201391.","journal-title":"Anticancer Res"},{"key":"285_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-9966-28-18","volume":"28","author":"MA Str\u00f6hlein","year":"2009","unstructured":"Str\u00f6hlein MA, Siegel R, J\u00e4ger M, Lindhofer H, Jauch K-W, Heiss MM. Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 2009;28:18.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"285_CR22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/IGC.0b013e3181a416d0","volume":"19","author":"B Cheng","year":"2009","unstructured":"Cheng B, Lu W, Xiaoyun W, YaXia C, Xie X. Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases. Int J Gynecol Cancer. 2009;19(4):611\u20134.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"285_CR23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0090-8258(03)00400-1","volume":"90","author":"G Cormio","year":"2003","unstructured":"Cormio G, Capotorto M, Di Vagno G, Cazzolla A, Carriero C, Selvaggi L. Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature. Gynecol Oncol. 2003;90(3):682\u20135.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"285_CR24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12032-009-9259-z","volume":"27","author":"S Demirci","year":"2010","unstructured":"Demirci S, Yavas F, Ozsaran Z, et al. Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature. Med Oncol. 2010;27(3):628\u201331.","journal-title":"Med Oncol"},{"issue":"1","key":"285_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00931405","volume":"244","author":"B Patsner","year":"1988","unstructured":"Patsner B, Mann WJ, Chumas J, Loesch M. Herpetiform cutaneous metastases following negative second look laparotomy for ovarian adenocarcinoma. Arch Gynecol Obstet. 1988;244(1):63\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"285_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0301-2115(95)02281-3","volume":"64","author":"F Flam","year":"1996","unstructured":"Flam F, Skoog L, Wilking N. Subcutaneous metastasis from an ovarian carcinoma disappeared following tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol. 1996;64(2):225\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"285_CR27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2125.2010.03635.x","volume":"69","author":"P Ruf","year":"2010","unstructured":"Ruf P, Kluge M, J\u00e4ger M, et al. Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients. Br J Clin Pharmacol. 2010;69(6):617\u201325.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"285_CR28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/030089169107700317","volume":"77","author":"O Merimsky","year":"1991","unstructured":"Merimsky O, Chaitchik S, Inbar M. Skin metastasis of ovarian cancer: report of three cases. Tumori. 1991;77(3):268\u201370.","journal-title":"Tumori"},{"issue":"4","key":"285_CR29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4103\/0019-5154.57620","volume":"54","author":"SJ Karpate","year":"2009","unstructured":"Karpate SJ, Samal SL, Jain SM. Recurrent ovarian malignancy presenting as cutaneous metastasis. Indian J Dermatol. 2009;54(4):380\u20131.","journal-title":"Indian J Dermatol"},{"issue":"5","key":"285_CR30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/DAD.0b013e3181c6dfc1","volume":"32","author":"D Lalich","year":"2010","unstructured":"Lalich D, Tawfik O, Chapman J, Fraga G. Cutaneous metastasis of ovarian carcinoma with shadow cells mimicking a primary pilomatrical neoplasm. Am J Dermatopathol. 2010;32(5):500\u20134.","journal-title":"Am J Dermatopathol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0285-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-012-0285-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-012-0285-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T10:45:52Z","timestamp":1561891552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-012-0285-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1007\/s12032-012-0285-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}